| Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies C Ceran Serdar, M Cihan, D Yücel, MA Serdar Biochemia Medica 31 (1), 2021 | 779 | 2021 |
| Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α C Ceran, M Cokol, S Cingoz, I Tasan, M Ozturk, T Yagci BMC cancer 12, 1-16, 2012 | 44 | 2012 |
| Kynurenine pathway in Coronavirus disease (COVID‐19): potential role in prognosis M Cihan, Ö Doğan, C Ceran Serdar, A Altunçekiç Yıldırım, C Kurt, ... Journal of clinical laboratory analysis 36 (3), e24257, 2022 | 25 | 2022 |
| Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients A Haşimi, Ö Doğan, CC Serdar, MA Serdar Biochemia medica 33 (1), 21-31, 2023 | 4 | 2023 |
| Exosomal prognostic biomarkers predict metastatic progression and survival in breast cancer patients C Ceran Serdar, Ş Osmanlıoğlu Turkish Journal of Biochemistry 48 (5), 541-562, 2023 | | 2023 |
| Does smoking influence tryptophan metabolism in periodontal inflammation? A cross‐sectional study C Önder, N Akdoğan, Ş Kurgan, N Balci, CC Serdar, MA Serdar, ... Journal of Periodontal Research 58 (5), 1041-1051, 2023 | | 2023 |
| SARS-CoV-2'nin Moleküler Gizemi ve Pandemiye Etkisi Molecular Mystery of SARS-CoV-2 and Its Role on COVID-19 Pandemic Ceyhan CERAN SERDAR, Yakut AKYÖN, Muhittin Abdülkadir SERDAR, Engin YILMAZ COVID - 19 Pandemisinde Tıbbi Biyokimyanın Artan Rolü, 1-12, 2021 | | 2021 |
| SARS-CoV-2'nin Moleküler Gizemi ve Pandemiye Etkisi CC SERDAR, Y AKYÖN, MA SERDAR, E YILMAZ Turkiye Klinikleri COVID-19 2 (2), 1-12, 2021 | | 2021 |
| Novel monoclonal antıbodıes targetıng conformatıonal ERBB2 epıtopes C Ceran Mühendislik ve Fen Bilimleri Enstitüsü, 2012 | | 2012 |
| Novel Monoclonal Antibodies Targeting Conformational ERBB2 Epitopes C Ceran PQDT-Global, 2012 | | 2012 |
